Germany’s Formycon has announced that the Brazilian regulatory authority Anvisa has granted marketing authorization for ...

A sweeping legislative package backed by US President Donald Trump could strip health insurance from more than 16 million ...

USA-based subsidiary Vividion Therapeutics has taken over full development and commercialization rights for VVD-214, a ...

The NHS Business Services Authority (NHSBSA) has published the annual Prescription Cost Analysis (PCA) for 2024/25.

The European Commission has granted market authorization for Japanese ophthalmic drugmaker Santen Pharmaceutical’s (TYO: 4536 ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to women taking popular medicines ...

Japanese drugmaker Shionogi and US pharma major Eli Lilly were among the big spenders in pharma M&A during May.

Italian drug discovery specialist Axxam and German AI firm Molecular Health have struck a strategic alliance aimed at ...

US clinical-stage biotech Vigil Neuroscience (Nasdaq: VIGL) today announced a disappointing update on the Phase II IGNITE ...

US biotech BioAge Labs (Nasdaq: BIOA) is expanding its obesity pipeline just months after shelving its lead drug in the ...

US clinical-stage biotech Sagimet Biosciences (Nasdaq: SGMT) today reported denifanstat met all primary and secondary ...

Danish dermatology specialist LEO Pharma has appointed Helle Hedegaard Juhl as executive vice president for global people and ...